Funding drought: how can biotech and biopharma keep trials running?
Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face government funding cuts.
Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face government funding cuts.
What's Your Reaction?
